ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

October 17, 1997

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

Federal Cigarettes Tax Extension Approved By Senate

October 4, 1985

President’s Surgery Stirs Interest In Colon Cancer Exams

July 26, 1985

Task Force Issues Guidless on LDCT Lung Screening

January 10, 2014

In Brief: Weldon Gage named CFO at MD Anderson Cancer Center

December 12, 2014